Jacob Waugh
2014
In 2014, Jacob Waugh earned a total compensation of $2.3M as Chief Scientific Officer at Revance Therapeutics, a 76% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $111,115 |
|---|---|
| Option Awards | $968,330 |
| Salary | $358,435 |
| Stock Awards | $805,500 |
| Other | $34,997 |
| Total | $2,278,377 |
Waugh received $968.3K in option awards, accounting for 43% of the total pay in 2014.
Waugh also received $111.1K in non-equity incentive plan, $358.4K in salary, $805.5K in stock awards and $35K in other compensation.
Rankings
In 2014, Jacob Waugh's compensation ranked 3,996th out of 13,032 executives tracked by ExecPay. In other words, Waugh earned more than 69.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,996 out of 13,032 | 69th |
Division Manufacturing | 1,410 out of 4,966 | 72nd |
Major group Chemicals And Allied Products | 457 out of 1,686 | 73rd |
Industry group Drugs | 352 out of 1,365 | 74th |
Industry Pharmaceutical Preparations | 281 out of 1,043 | 73rd |
Source: SEC filing on March 26, 2015.
Waugh's colleagues
We found three more compensation records of executives who worked with Jacob Waugh at Revance Therapeutics in 2014.